Showing results (131-140 of 367) with videos related to
Sort By:
Pageof 37
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 22, 2025
Multicancer Early Detection Tests at a Crossroads: Commercial Availability Ahead of Definitive EvidenceCarmen E Guerra, Jennifer Keating Litton, Carolina E Viswanath, et al.Acta Cytologica|June 7, 2003
Endoscopic ultrasound-guided fine needle aspiration of the pancreas. Diagnostic utility and accuracyAlaa M Afify, Basim M al-Khafaji, Byungki Kim, et al.The American Journal of Gastroenterology|October 16, 2008
Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet AgentsFrancis K L Chan, Neena S Abraham, James M Scheiman, et al.Journal of Cardiovascular Pharmacology|March 23, 2016
Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and UlcersJay L Goldstein, James M Scheiman, John G Fort, et al.Gastrointestinal Endoscopy|October 2, 2003
EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasiaErik-Jan Wamsteker, Paul G Gauger, Norman W Thompson, et al.Journal of General Internal Medicine|July 1, 2006
Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisitedBrian D De Smet, A Mark Fendrick, James G Stevenson, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 24, 2018
GLUCAGON PRESCRIPTIONS FOR DIABETES PATIENTS AFTER EMERGENCY DEPARTMENT VISITS FOR HYPOGLYCEMIAA Mark Fendrick, Xuanyao He, Dongju Liu, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 29, 2002
Is sepsis accurately coded on hospital bills?Daniel A Ollendorf, A Mark Fendrick, Karen Massey, et al.Cancer|July 15, 2024
Out-of-pocket costs for diagnostic testing following abnormal prostate cancer screening among privately insured menArnav Srivastava, Anca Tilea, David D Kim, et al.Journal of Managed Care & Specialty Pharmacy|April 23, 2025
Brand-to-brand nonmedical switching among interleukin-17 inhibitors or other biologics: Implications of a formulary changeA Mark Fendrick, Manish Mittal, Yi Peng, et al.Pageof 37